CD274 and neoplasm: EVs engineered to carry anti-PD-L1 siRNA were delivered to the GBM tumor, with researchers looking to decrease the levels of PD-L1 because this ligand, aptly named the programmed death ligand, allows cancer cells to slip past the immune system and avoid apoptosis [14,30].